Lilly on a roll, up 15% this week on GLP1 research news.
#Mounjaro and #Zepbound are chasing the face of medicine, treating #diabetes, #obesity, #cardiovascular disease, #dementia and even #SleepApnea — all game changers! Revolutionary
Lilly licensed orforglipron from Chugai in 2018. Now both companies’ stocks are soaring as the pill shows potential for blockbuster status in the weight-loss drug market. https://www.japantimes.co.jp/business/2025/04/18/companies/weight-loss-drug-orforglipron/?utm_medium=Social&utm_source=mastodon #business #companies #pharmaceuticals #obesity #mounjaro #ozempic #elililly #chugai #orforglipron #health
New Review and Meta-Analysis confirms weight gain with discontinuance of #Semaglutide and #Tirzepatide
Discontinuing GLP1 medications led to a pooled overall mean weight regain of 9.69 kg (or about 22 lbs in patients prescribed semaglutide/tirzepatide. The proportion of weight regained was proportional to the amount originally lost.
Discontinuation of GLP-1RA treatment leads to weight regain, regardless of lifestyle interventions, and should therefore be considered a chronic therapy to prevent weight regain and associated undesirable outcomes related to #Obesity.
#wegovy #ozempic #mounjaro #zepbound
https://onlinelibrary.wiley.com/doi/10.1111/obr.13929
Mein #Mounjaro Update nach einer Woche. Ich habe 4.9kg abgenommen und freue mich auf meine zweite Injektion :)
#mounjaro
Urgh I hate the first 36 hours after the jab, I’m a little over 12 hours in and I feel soo sick I’m not going to sleep well tonight either 
GLP-1s Are Crazy Effective — Just Not Cost-Effective
I’ll make the argument that the most effective drugs in the past decade are the GLP-1 receptor agonists, drugs like semaglutide and tirzepatide. At least in terms of weight loss, they are truly unparalleled. They are clearly effective. But are they worth it? Are they cost-effective? That is a much harder question, and, as you’ll see in a minute, despite their amazing effects, the answer — for now, at least — is no.
#mounjaro #ozempic #zepbound #wegovy #glp1
https://www.medscape.com/viewarticle/glp-1s-are-crazy-effective-just-not-cost-effective-2025a10006es?form=fpf
Auwei da kann einem ja Angst und Bange werden.
Da muss ich sofort Dokta Guugel befragen und medizinalheilkräftige Webseiten studieren 
Zitat:
#Semaglutid und #Tirzepatid ( #Wegovy #Ozempic #mounjaro ) werden seit langem als Durchbruch im Kampf gegen #Fettleibigkeit und #Typ2Diabetes gepriesen.
- angeblich auch schwere psychische Probleme auslösen
-mehr als 2000 Nutzer der Injektionen - Hilfe wegen #Panikattacken und schwerer #Angstzustände gesucht haben
https://www.bz-berlin.de/ratgeber/abnehmspritze-angstattacken
Forget Psychedelics 
Everyone’s Microdosing Ozempic Now 
“Shamoon has joined the wave of people who are taking limited amounts not of psychedelics — to which the microdosing trend usually applies — but of the diabetes drug #Ozempic (#semaglutide), and other #GLP1 receptor agonists like #Mounjaro
They are doing it not primarily for weight loss — the effect that has made Ozempic a Hollywood staple and a reliable awards-show punchline — but for the surprising and widely touted side benefits, particularly its anti-inflammatory properties”
Ozempic blindness? Serious vision problems reported in patients taking weight loss medications https://www.psypost.org/ozempic-blindness-serious-vision-problems-reported-in-patients-taking-weight-loss-medications/?utm_source=dlvr.it&utm_medium=mastodon #Ozempic #Mounjaro #DiabetesAwareness #WeightLoss #VisionProblems
Lilly’s Zepbound Beats Wegovy in First Head-to-Head Study
Eli Lilly’s Zepbound #Obesity drug helped people lose significantly more weight than its main competitor, Novo Nordisk’s Wegovy.
People taking Zepbound lost 20.2% of their body weight on average after 72 weeks of treatment in the Lilly-sponsored study, compared with a 13.7% loss for Wegovy patients, Lilly said Wednesday.
That translated into an average 50-pound loss for people who took Zepbound, while Wegovy users lost 33 pounds.
PS: #Zepbound and #Mounjaro are the same drug with different brand names, as are #Ozempic and #Wegovy.
Amazing!
GLP-1 medications like #Ozempic and #Mounjaro are reducing ‘all cause’ hospitalizations and bariatric surgery.
Researchers recently found a 132.6% increase in #GLP1 prescriptions and a 25.6% decline in bariatric surgeries between 2022 and 2023. The results add empirical evidence to a trend of declining operations that bariatric surgeons have been noticing for months.
A Novo Nordisk trial also discovered an association between Wegovy prescriptions and fewer hospitalizations for any cause”
#obesity #wegovy #zepbound
https://www.beckershospitalreview.com/pharmacy/3-ozempic-updates-competition-warnings-and-potential-uses.html?origin=BHRSUN&oly_enc_id=7342A2767601A3R
#Obesity Drug Shows Promise in Easing Knee #Osteoarthritis Pain
As a practicing physician, I've seen up close the remarkable benefits of the #GLP1 class of medications, including #semaglutide (#Ozempic, #Wegovy) and #tirzepatide (#Mounjaro, #Zepbound.)
Reduction in weight (and inflammation) are game changers.
Better control of #Diabetes, reduced #Cardiovascular and #Stroke risk, maybe lower incident of #Dementia, #MultipleSclerosis and other diseases which have an 'inflammatory' component.
All we need now is to lower the cost (about $1,000/month in the US; heard the price is $59 in EU!)
https://www.nytimes.com/2024/10/30/health/ozempic-wegovy-knee-pain-osteoarthritis.html
Who needs a #GLP1 when you have this? Move over Ozempic!
"We've developed a molecule that can mimic the body's natural metabolic response to strenuous exercise and fasting.
In practice, the molecule brings the body into a metabolic state corresponding to running 10 kilometers at high speed on an empty stomach," explains Professor Thomas Poulsen from the Department of Chemistry at Aarhus University"
#ozempic #mounjaro #zepbound #wegovy #tirezepatide #semaglutide #obesity #weightloss #longevity
https://phys.org/news/2024-10-molecule-mimic-effects-fasting.html
@3x10to8mps
Sorry for all the trouble you've had 
As I've seen in my practice, most of the side effects can be dealt with dietary changes.
And as usual, in the crazy American #Healthcare system, we have two names for one drug:
#Ozempic (diabetes) and #Wegovy (obesity, with slight difference in dose) = #semaglutide
#Mounjaro (#diabetes) and #Zepbound (#obesity, same exact dose) = #tirezepatide.
I've created this informational instruction page with dietary hints for my patients:
Doctors Wish More People Over 65 Took Ozempic
Millions of people are flocking to drugs like #Ozempic and #Wegovy to lose weight and treat health problems. Doctors say one group that could benefit from the drugs is missing out: seniors.
For older people, these medications can help in ways that go beyond losing weight, physicians say. Fewer pounds can lead to more mobility and better balance, allowing older people to become more active. That can boost mood, overall health, and sometimes makes the difference between walking freely or using a wheelchair or cane.
#mounjaro #zepbound #glp1 #obesity
https://apple.news/Aiz7CIM58Qv-tvbGUuElibQ
Ozempic and cancer: What to know
Labels for #GLP1 medications, like #Ozempic and #Mounjaro, might see more approved uses as researchers study the drugs' effects on #SleepApnea, #Dementia and other health issues. Meanwhile, oncologists are looking at a GLP-1 role in #Cancer care.
Several studies have shown the therapies — currently approved for Type 2 #diabetes and weight loss — can diminish the risk of multiple cancers:
#obesity #glp
https://www.beckershospitalreview.com/glp-1s/ozempic-and-cancer-what-to-know.html?origin=BHRE
Mounjaro is no longer covered by my insurance.
Best healthcare in the world. /s
(I don’t use it for weight loss)
Mechanic 
